Therapeutic Solutions International, Inc.
TSOI
Rank in Stocks
#34159
Therapeutic Solutions International, Inc. is dedicated to modulating the immune... Therapeutic Solutions International, Inc. is dedicated to modulating the immune system to address a diverse array of serious conditions. The company formulates immune-modulatory agents targeting cancers, schizophrenia, suicidal ideation, and various neurological disorders like traumatic brain injury and chronic traumatic encephalopathy, alongside lung pathologies and general health maintenance. Its premier product, QuadraMune, is a patented, synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone, engineered to amplify natural killer cell activity and foster healthy cytokine production. In addition to QuadraMune, the company provides a range of nutraceuticals. These include ProJuvenol, an anti-aging capsule blend; various pterostilbene formulations like NanoStilbene (a nanoemulsion), DermalStilbene (a topical spray), IsoStilbene (an injectable form), and NeuroStilbene (an intranasal version); Nano Cannabidiol, a nanoparticle cannabidiol, and its composite NanoPlus (with NanoStilbene); as well as specialized blends such as NanoPSA (combining NanoStilbene and broccoli sprout extract) and the NLRP3 Trifecta (a two-product system with NanoPSA and GTE-50 green tea extract). Furthermore, the company is actively developing advanced therapeutics for chronic traumatic encephalopathy, traumatic brain injury, and lung diseases. Founded in 2007, Therapeutic Solutions International, Inc. is headquartered in Elk City, Idaho.
Share Price
$0.00001
Last synced: 2026-11-06
Market Cap
$51.23K
Change (1 day)
0.00%
Change (1 year)
900.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Therapeutic Solutions International, Inc. (TSOI)
Category
Healthcare
Operating Margin for Therapeutic Solutions International, Inc. (TSOI)
Operating Margin as of November 2026 TTM: -2,006.67%
According to Therapeutic Solutions International, Inc.'s latest financial reports, its current operating margin (TTM) is -2,006.67%. At the end of 2023 the company had an operating margin of -2,006.67%.
Operating Margin history for Therapeutic Solutions International, Inc. from 2007 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -2,006.67% | 0.00% |
| 2023 | -2,006.67% | 26.52% |
| 2022 | -1,586.03% | 0.46% |
| 2021 | -1,578.79% | -46.50% |
| 2020 | -2,950.78% | -22.23% |
| 2019 | -3,794.02% | -88.98% |
| 2018 | -34,437.69% | 11.03% |
| 2017 | -31,016.03% | 49.07% |
| 2016 | -20,805.97% | -30.36% |
| 2015 | -29,876.24% | 24,459.18% |
| 2014 | -121.65% | -32.33% |
| 2013 | -179.76% | 221.40% |
| 2012 | -55.93% | -9.38% |
| 2011 | -61.72% | 0.00% |
| 2010 | 0.00% | 0.00% |
| 2009 | 0.00% | 0.00% |
| 2008 | 0.00% | 0.00% |
| 2007 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.02% |
US
|
|
| -149.01% | -99.93% |
US
|
|
| 25.57% | -100.01% |
AU
|
|
| 31.23% | -100.02% |
BE
|
|
| 29.35% | -100.01% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Therapeutic Solutions International, Inc.'s operating margin
What is Therapeutic Solutions International, Inc.'s operating margin?
Therapeutic Solutions International, Inc.'s operating margin is -2,006.67%, as of Nov 2026.
What was Therapeutic Solutions International, Inc.'s operating margin in 2023?
In 2023, Therapeutic Solutions International, Inc.'s operating margin was -2,006.67%, compared with -1,586.03% in 2022.
How has Therapeutic Solutions International, Inc.'s operating margin changed since 2018?
From 2018 to 2023, Therapeutic Solutions International, Inc.'s operating margin was highest in 2021 (-1,578.79%) and lowest in 2018 (-34,437.69%).
How does Therapeutic Solutions International, Inc.'s operating margin compare with similar companies?
Therapeutic Solutions International, Inc.'s operating margin (-2,006.67%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.